Free Trial

MoonLake Immunotherapeutics (MLTX) Institutional Ownership

MoonLake Immunotherapeutics logo
$54.84 +1.46 (+2.74%)
Closing price 04:00 PM Eastern
Extended Trading
$54.90 +0.06 (+0.12%)
As of 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for MoonLake Immunotherapeutics (NASDAQ:MLTX)

Current
Institutional Ownership
Percentage
93.85%
Number of
Institutional Buyers
(last 12 months)
76
Total
Institutional Inflows
(last 12 months)
$463.27M
Number of
Institutional Sellers
(last 12 months)
46
Total
Institutional Outflows
(last 12 months)
$301.25M
Get MLTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling MoonLake Immunotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MLTX Institutional Buying and Selling by Quarter

MoonLake Immunotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2025JPMorgan Chase & Co.39,397$1.86M0.0%+4,584.5%0.062%
8/12/2025DNB Asset Management AS9,585$452K0.0%-7.0%0.015%
8/12/2025Swiss National Bank42,300$2.00M0.0%-1.6%0.066%
8/12/2025Handelsbanken Fonder AB10,600$500K0.0%-4.5%0.017%
8/12/2025Westfield Capital Management Co. LP1,259,376$59.44M0.2%-12.2%1.967%
8/11/2025Universal Beteiligungs und Servicegesellschaft mbH12,790$604K0.0%-13.5%0.020%
8/8/2025 Candriam S.C.A.144,830$6.84M0.0%-17.0%0.226%
8/8/2025 Geode Capital Management LLC59,553$2.81M0.0%+0.9%0.093%
8/8/2025 PNC Financial Services Group Inc.4,340$205K0.0%-52.8%0.007%
8/4/2025 Moody Aldrich Partners LLC54,416$2.57M0.5%-1.5%0.085%
8/1/2025 Jennison Associates LLC62,318$2.94M0.0%N/A0.097%
8/1/2025 Envestnet Asset Management Inc.11,949$564K0.0%-16.0%0.019%
7/28/2025 TD Asset Management Inc186,152$8.79M0.0%-14.2%0.291%
7/9/2025 Harbor Capital Advisors Inc.51,409$2.43M0.1%-49.6%0.080%
6/18/2025Voya Investment Management LLC392,924$15.35M0.0%-12.5%0.614%
5/16/2025Woodline Partners LP296,148$11.57M0.1%+0.9%0.463%
5/16/2025Zimmer Partners LP24,500$957K0.0%N/A0.038%
5/16/2025Octagon Capital Advisors LP296,000$11.57M1.2%N/A0.462%
5/16/2025Caxton Associates LLP8,880$347K0.0%N/A0.014%
5/16/2025Fred Alger Management LLC642,881$25.12M0.1%-4.6%1.004%
5/16/2025Goldman Sachs Group Inc.1,292,608$50.50M0.0%-22.8%2.019%
5/16/2025Millennium Management LLC344,320$13.45M0.0%+3,343.2%0.538%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.13,933$544K0.0%-9.9%0.022%
5/16/2025Granahan Investment Management LLC142,220$5.56M0.3%+4.2%0.222%
5/16/2025Alliancebernstein L.P.966,090$37.75M0.0%-5.5%1.509%
5/16/2025Advisors Asset Management Inc.4,009$157K0.0%+81.7%0.006%
5/16/2025ADAR1 Capital Management LLC5,424$212K0.0%-68.9%0.008%
5/15/2025Vestal Point Capital LP200,000$7.81M0.6%N/A0.312%
5/15/2025Birchview Capital LP8,000$313K0.3%+100.0%0.012%
5/15/2025MPM Bioimpact LLC316,049$12.35M2.1%+0.3%0.494%
5/15/2025Cubist Systematic Strategies LLC24,819$970K0.0%N/A0.039%
5/15/2025Royal Bank of Canada15,554$608K0.0%-2.1%0.024%
5/15/2025Quarry LP2,400$94K0.0%N/A0.004%
5/15/2025Paradigm Biocapital Advisors LP627,423$24.51M1.2%-64.6%0.980%
5/14/2025Walleye Capital LLC26,764$1.05M0.0%-87.2%0.042%
5/14/2025Price T Rowe Associates Inc. MD2,973,830$116.19M0.0%-11.1%4.646%
5/14/2025 Candriam S.C.A.174,520$6.82M0.0%-23.3%0.273%
5/14/2025Wellington Management Group LLP32,163$1.26M0.0%-67.5%0.050%
5/13/2025Russell Investments Group Ltd.5,460$213K0.0%-90.2%0.009%
5/12/2025Nuveen LLC673,343$26.31M0.0%N/A1.052%
Elon Musk: “Nothing happens without this…” (Ad)

Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electric vehicles could fail to reach production—and the AI revolution could stall. After a year of research, one small-cap stock has emerged as the top contender to benefit from a looming supply crunch.

See the Element 29 stock poised for a potential 3,500% windfall
5/9/2025Westfield Capital Management Co. LP1,434,770$56.06M0.3%+9.4%2.241%
5/9/2025 BIT Capital GmbH14,610$571K0.0%-29.6%0.023%
5/9/2025 PNC Financial Services Group Inc.9,200$359K0.0%+8.2%0.014%
5/8/2025Jefferies Financial Group Inc.10,000$391K0.0%+60.0%0.016%
5/8/2025 US Bancorp DE2,208$86K0.0%+114.4%0.003%
5/8/2025XTX Topco Ltd8,495$332K0.0%N/A0.013%
5/8/2025Federated Hermes Inc.1,269,351$49.59M0.1%-0.8%1.983%
5/7/2025 TD Asset Management Inc216,904$8.47M0.0%-17.1%0.339%
5/6/2025Legato Capital Management LLC6,142$240K0.0%N/A0.010%
5/6/2025Universal Beteiligungs und Servicegesellschaft mbH14,790$578K0.0%-26.6%0.023%
5/2/2025Victory Capital Management Inc.258,150$10.09M0.0%+44.6%0.403%
5/1/2025Rice Hall James & Associates LLC137,516$5.37M0.3%+23.7%0.215%
5/1/2025New York State Common Retirement Fund6,992$273K0.0%N/A0.011%
4/30/2025Alps Advisors Inc.47,101$1.84M0.0%-7.6%0.074%
4/29/2025 Envestnet Asset Management Inc.14,225$556K0.0%+58.6%0.022%
4/29/2025 Moody Aldrich Partners LLC55,245$2.16M0.5%N/A0.086%
4/28/2025 Teacher Retirement System of Texas5,940$232K0.0%-9.1%0.009%
4/14/2025 Harbor Capital Advisors Inc.102,020$3.99M0.2%+28.1%0.159%
3/24/2025Wellington Management Group LLP99,098$5.37M0.0%-48.4%0.155%
2/28/2025Universal Beteiligungs und Servicegesellschaft mbH20,141$1.09M0.0%N/A0.032%
2/27/2025Jefferies Financial Group Inc.6,250$338K0.0%N/A0.010%
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC42,236$2.29M0.0%+17.9%0.066%
2/17/2025Woodline Partners LP293,535$15.90M0.1%+26.3%0.459%
2/17/2025Wexford Capital LP24,000$1.30M0.2%+71.4%0.038%
2/17/2025Point72 Asset Management L.P.98,719$5.35M0.0%N/A0.154%
2/17/2025Polar Capital Holdings Plc1,100,000$59.57M0.3%+120.0%1.721%
2/17/2025MPM Bioimpact LLC315,230$17.07M2.4%-9.7%0.493%
2/17/2025Paradigm Biocapital Advisors LP1,772,211$95.97M3.3%+90.3%2.773%
2/17/2025Parkman Healthcare Partners LLC54,294$2.94M0.4%-47.2%0.085%
2/17/2025Nuveen Asset Management LLC595,581$32.25M0.0%+2.5%0.932%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC20,740$1.12M0.1%+29.6%0.032%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.15,456$837K0.0%+13.7%0.024%
2/17/2025Integral Health Asset Management LLC200,000$10.83M0.9%-9.1%0.313%
2/17/2025Jefferies Financial Group Inc.6,250$338K0.0%N/A0.010%
2/17/2025Granahan Investment Management LLC136,438$7.39M0.3%-21.0%0.214%
2/17/2025Ensign Peak Advisors Inc9,139$495K0.0%-78.4%0.014%
2/17/2025Fred Alger Management LLC673,773$36.49M0.2%+1.1%1.054%
2/17/2025Deutsche Bank AG903$49K0.0%+59.8%0.001%
2/17/2025Caption Management LLC12,371$670K0.0%N/A0.019%
2/17/2025BVF Inc. IL19,751,284$1.07B36.3%-9.2%30.910%
2/17/2025Balyasny Asset Management L.P.206,568$11.19M0.0%-42.7%0.323%
2/17/2025Bank of America Corp DE45,540$2.47M0.0%-62.7%0.071%
2/17/2025BNP Paribas Financial Markets7,633$413K0.0%N/A0.012%
2/17/2025Ameriprise Financial Inc.204,373$11.07M0.0%+28.3%0.320%
2/14/2025Schonfeld Strategic Advisors LLC3,911$212K0.0%-95.5%0.006%
2/14/2025Northern Trust Corp14,261$772K0.0%+161.7%0.022%
2/14/2025The Manufacturers Life Insurance Company142,702$7.73M0.0%+20.8%0.223%
2/14/2025Decheng Capital LLC171,600$9.29M2.0%+3.0%0.269%
2/14/2025Birchview Capital LP4,000$217K0.2%N/A0.006%
2/14/2025Virtus ETF Advisers LLC1,322$72K0.0%-38.9%0.002%
My shocking meeting in Washington, D.C. (Ad)

After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look inside Trump’s genius master plan to create a “new” gold standard, smash the U.S. debt, and kick off a Golden Century.

2/14/2025Voya Investment Management LLC448,860$24.31M0.0%+9.7%0.702%
2/14/2025Adage Capital Partners GP L.L.C.155,000$8.39M0.0%-69.3%0.243%
2/14/2025Hood River Capital Management LLC649,590$35.18M0.5%+0.5%1.017%
2/14/2025Price T Rowe Associates Inc. MD3,343,643$181.06M0.0%+12.2%5.233%
2/14/2025Dimensional Fund Advisors LP64,384$3.49M0.0%N/A0.101%
2/13/2025Marshall Wace LLP1,245,299$67.43M0.1%+7.9%1.949%
2/13/2025PEAK6 LLC5,000$271K0.0%N/A0.008%
2/13/2025Mariner LLC5,028$272K0.0%N/A0.008%
2/13/2025Barclays PLC4,646$252K0.0%-17.6%0.007%
2/13/2025Legal & General Group Plc19,480$1.06M0.0%-6.6%0.030%
(Data available from 1/1/2016 forward)

MLTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MLTX shares?

During the previous two years, 132 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were BVF Inc. IL ($1.07B), Cormorant Asset Management LP ($415.25M), FMR LLC ($343.39M), Avoro Capital Advisors LLC ($121.80M), Price T Rowe Associates Inc. MD ($116.19M), Holocene Advisors LP ($79.92M), and Marshall Wace LLP ($67.43M).Learn more on MoonLake Immunotherapeutics' institutional investors.

What percentage of MoonLake Immunotherapeutics' stock is owned by institutional investors?

93.85% of MoonLake Immunotherapeutics' stock is owned by institutional investors. Learn more on MLTX's institutional investor holdings.

Which institutional investors have been buying MoonLake Immunotherapeutics' stock?

Of the 112 institutional investors that purchased MoonLake Immunotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.72M), Cormorant Asset Management LP ($1.25M), Paradigm Biocapital Advisors LP ($840.73K), Avoro Capital Advisors LLC ($770.00K), Logos Global Management LP ($750K), Westfield Capital Management Co. LP ($692.48K), and Marshall Wace LLP ($678.60K).

How much institutional buying is happening at MoonLake Immunotherapeutics?

Institutional investors have bought a total of 9,549,968 shares in the last 24 months. This purchase volume represents approximately $463.34M in transactions.

Which of MoonLake Immunotherapeutics' major shareholders have been selling company stock?

Of the 47 institutional investors that sold MoonLake Immunotherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BVF Inc. IL ($2M), Paradigm Biocapital Advisors LP ($1.14M), Wellington Management Group LLP ($433.45K), Goldman Sachs Group Inc. ($382.06K), Price T Rowe Associates Inc. MD ($369.81K), Adage Capital Partners GP L.L.C. ($350K), and Integral Health Asset Management LLC ($220K).

How much institutional selling is happening at MoonLake Immunotherapeutics?

Institutional investors have sold a total of 6,355,285 shares in the last 24 months. This volume of shares sold represents approximately $301.47M in transactions.



This page (NASDAQ:MLTX) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners